TY - JOUR T1 - NSAIDs for analgesia in the era of COVID-19 JF - Regional Anesthesia & Pain Medicine JO - Reg Anesth Pain Med SP - 677 LP - 678 DO - 10.1136/rapm-2020-101584 VL - 45 IS - 9 AU - Daniel L Herzberg AU - Harry P Sukumaran AU - Eugene Viscusi Y1 - 2020/09/01 UR - http://rapm.bmj.com/content/45/9/677.abstract N2 - Globally, non-steroidal anti-inflammatory drugs (NSAIDs) are highly used to treat pain. With the rise of the COVID-19 pandemic, the safety of NSAIDs use has been called into question. These concerns are worthy of review. At present, there is no compelling data showing that NSAIDs worsen the severity of COVID-19 symptoms or increase one’s likelihood of contracting the illness. For patients in pain and without symptoms that could potentially be attributed to COVID-19 (cough, fevers/chills, lethargy, myalgias, anosmia and so on), NSAIDs should continue to remain a viable option to provide analgesia to patients in need. ER -